Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|6|719-730

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.6, 2015-09, pp. : 719-730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relative bioavailability of a 5 mg mosapride/10 mg rabeprazole fixed dose combination tablet versus separate single tablets in healthy volunteers: a single-dose randomized open-label crossover study

By Keller G.A.   Czerniuk P.   Bertuola R.   de Mena F.   Simoni M.V.   Assefi A.R.   Di Girolamo G.  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2203-2211

Informa Healthcare

Access to resources Recommend Favorite

Meta-Analysis of the Efficacy of Ebastine 20 mg Compared to Loratadine 10 mg and Placebo in the Symptomatic Treatment of Seasonal Allergic Rhinitis

By  

International Archives of Allergy and Immunology, Vol. 138, Iss. 4, 2005-11 ,pp. : 312-318

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Ebastine 20 mg Compared to Loratadine 10 mg Once Daily in the Treatment of Seasonal Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Study

By  

International Archives of Allergy and Immunology, Vol. 133, Iss. 4, 2004-04 ,pp. : 371-379

Karger

Access to resources Recommend Favorite

Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 636-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comment and reply on: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination

By Vivencio Barrios   Norbert Braun  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2267-2269

Informa Healthcare

Access to resources Recommend Favorite